Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndromeVincenzo Di Stefano, Filippo Brighina, Massimiliano Militello et al.|Journal of Neurology|2023Cited by 52
A real-life experience with eculizumab and efgartigimod in generalized myasthenia gravis patientsChiara Pane, Francesco Saccà, Vincenzo Di Stefano et al.|Journal of Neurology|2024Cited by 49
Diagnosis and Management of Seronegative Myasthenia Gravis: Lights and ShadowsClaudia Vinciguerra, Vincenzo Di Stefano, Filippo Brighina et al.|Brain Sciences|2023Cited by 47